Are you a first-time investor? Here are some of the best mutual funds to consider
Are you a first-time investor? Here are some of the best mutual funds to consider

Are you a first-time investor? Here are some of the best mutual funds to consider

If you are a first-time investor, we are sure you are perplexed by the thousands of mutual funds available. Don't be concerned! In this article, we have listed top five mutual funds worth considering.

Henil Shah Article rating: 4.0

If you are a first-time investor, we are sure you are perplexed by the thousands of mutual funds available. Don't be concerned! In this article, we have listed top five mutual funds worth considering.

Watch out for these penny stocks locked in the upper circuit on January 27!
Watch out for these penny stocks locked in the upper circuit on January 27!

Watch out for these penny stocks locked in the upper circuit on January 27!

The Indian indices experienced a scene of carnage in bearish market tone and F&O expiry ahead of Union Budget on February 1.

Kaustubh Bhosale Article rating: 4.4

The Indian indices experienced a scene of carnage in bearish market tone and F&O expiry ahead of Union Budget on February 1. The benchmark indices at BSE and NSE tanked by over 1.63 per cent and 1.91 per cent. The BSE Sensex index had a major fall of 949 and is trading at a level of 56,916.00. The BSE Information Technology and Healthcare sector were the most affected ones and dragged down the index. Today the FII net selloff was recorded at Rs -7094 crore and DII Inflow Rs 4534 crore was recorded.

Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets
Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets

Glenmark Pharma receives USFDA approval for manufacturing blood pressure tablets

These tablets are the generic version of Ziac Tablets, which are manufactured by Teva Branded Pharmaceutical Products R&D, Inc.

Shruti Dahiwal Article rating: 4.5

These tablets are the generic version of Ziac Tablets, which are manufactured by Teva Branded Pharmaceutical Products R&D, Inc. 

Watch out for these low-priced stocks which made a fresh 52-week high on Thursday
Watch out for these low-priced stocks which made a fresh 52-week high on Thursday

Watch out for these low-priced stocks which made a fresh 52-week high on Thursday

The only gainers of Nifty 50 were Cipla, Axis Bank, and ONGC. Meanwhile, the top five stocks pulling down the index include HCL Technologies, Titan Company, Wipro, Eicher Motors, and Tata Steel.

Shreya Chaware Article rating: 4.7

At 12.30 pm on Thursday, the core equity indices i.e., Sensex and Nifty 50 were seen extending losses and were trading at a discount of more than 2 per cent. The Sensex was at 56,554.22 down by 1303.93 points or 2.25 per cent, while Nifty was at 16,934.90 down by 343.05 points or 1.99 per cent from the last trading session. 

Five stocks witnessing short covering
Five stocks witnessing short covering

Five stocks witnessing short covering

Short covering refers to buying back borrowed securities in order to close out an open short position at a profit or loss.

Avalokita Pandey Article rating: 4.5

List of the stocks where sell positions are being covered in the F&O segment.

Five stocks witnessing long unwinding
Five stocks witnessing long unwinding

Five stocks witnessing long unwinding

Long unwinding refers to selling of positions or stocks owned for a longer period either to book profit or to exit it in anticipation of impending bearishness.

Avalokita Pandey Article rating: 5.0

Following are the stocks where profit booking is seen taking place in the F&O segment.

RSS
First20382039204020412043204520462047Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR